China's vaccine research and development has made a great contribution to the global fight against the epidemic

On the 29th, representatives of national envoys and international organizations from Europe, Asia and Latin America visited the China Bio-Beijing Biological Products Research Institute of The National Pharmaceutical Group to learn about the latest achievements in the development of China's new crown vaccine.
visitors said the visit showed the world that China had laid a strong guarantee for the world to win the battle against the new crown pneumonia.
Malaysia's Ambassador to China, Raja Dato Nusirvan: China has made great progress in many vaccines, which sends a positive signal to the global fight against the epidemic, and today we understand that China has the ability to produce a fair amount of vaccines, which is a huge contribution to the world.
said that China's vaccine is currently in a number of countries to carry out Phase III clinical trials, and progress is smooth.
, according to authoritative research, China's vaccine can be stored and transported with the help of the existing cold chain system, and is more widespread.
, Chairman of The National Pharmaceutical Group: We are the normal transport at 2-8 degrees C, so far, the virus mutation does not affect the effectiveness of the vaccine.
next year, vaccine production could reach one billion doses.
October, China joined the new crown pneumonia vaccine implementation plan, and representatives of various countries and international organizations believe that China is taking concrete action to promote the fair distribution of vaccines and fulfill its commitment to make the new crown vaccine a global public product.
Sri Lanka's Ambassador to China, Eugena Dan: China's commitment to vaccines as a global public product has made vaccines accessable to everyone, especially for developing countries in urgent need of vaccines, Sri Lanka has learned a lot from China, and we are actively communicating with the Chinese government and scientific institutions on the field of vaccines.
Magnus Jurum, Counsellor at the Embassy of the Kingdom of Norway in China: China's commitment demonstrates its responsibility as a great power, and today we understand the speed with which China develops vaccines and the high standards it has for production, and we in Norway are working closely with China, especially in the field of vaccines.